Grindeks AS operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Grindeks AS with three other
pharmaceutical manufacturers in Europe:
Opus Global Nyrt
sales of 42.55 billion Hungarian Forints [US$153.19 million]
of which 70%
Dottikon ES Holding AG
(151.75 million Swiss Francs [US$156.76 million]
of which 89%
was Pharma Products), and
Eckert & Ziegler Strahlen- und Medizinte
based in Germany
(138.63 million Euro [US$161.76 million]
of which 62%
was Isotope Products).
During the year ended December of 2017, sales at
Grindeks AS were 132.41 million Euro (US$154.50 million).
increase of 25.7%
versus 2016, when the company's sales were 105.37 million Euro.